This fund seeks to track the performance of companies in the healthcare services sub-industry of the U.S. equity market. It targets medical infrastructure and managed health services, among other areas.

It is well suited for investors seeking diversified exposure to the long-term growth of the services and infrastructure sub-industries within the U.S. healthcare sector.

The fund is a passively managed (index-tracking) ETF operated by State Street.

The portfolio is constructed by selecting healthcare services companies from the broader S&P market universe. An equal-weight methodology is applied, which lowers the concentration of large-cap names and increases exposure to mid- and small-cap companies, providing broad representation across the sub-industry.

• Equal-weight methodology avoids concentration in any single large-cap name
• Targeted exposure to the healthcare services sub-industry

Assets under management (AUM) stand at $220.4M, with a total expense ratio of 0.35% annually.

The equal-weight approach reduces dependence on the performance of any single company, allowing investors to participate in the broad-based growth of the healthcare services sector.

Backed by long-term structural themes such as population aging and rising demand for medical services, the fund has attracted steady investor interest, while regulatory shifts and cost-containment pressures have driven short-term volatility.

Capital inflows and outflows tend to respond to innovation in medical infrastructure and services as well as to U.S. government policy changes. In particular, around elections or during debates over major healthcare legislation, investor sentiment toward the broader healthcare services industry can shift, influencing fund flows.

Even diversification that avoids concentration in any single large-cap name is a strength, but the elevated mid- and small-cap exposure can lead to higher volatility.

The ETFs listed in the table, including XLV, VHT, and FHLC, are large funds that invest across the broader U.S. healthcare sector using market-cap weighting and tend to charge relatively lower expense ratios. Meanwhile, those looking to focus on biotech may consider XBI, those targeting medical devices may consider IHI, and those seeking healthcare providers may consider IHF as alternative options.

Key points to review before investing in XHS. In addition to the effect of the equal-weight methodology in increasing mid- and small-cap exposure within a portfolio, U.S. government healthcare policy change risk should be carefully assessed in advance.

Checkpoint	Item to Verify	Current Status
⚖️ Weighting Method	Equal-weight methodology applied	Confirmed
🏛️ Regulatory Impact	U.S. Changes in government regulation and healthcare reimbursement policy can have an immediate impact on the profitability of healthcare services companies, while the elevated volatility of mid- and small-cap names poses a short-term risk. The fund is a useful vehicle for investors seeking broad-based exposure across the U.S. healthcare services industry. It is well suited for those who want differentiated exposure relative to large-cap-dominated healthcare ETFs. Reading alone isn't enough, is it? Make your own call with State Street SPDR S&P Health Care Services ETF real-time data → Briefs · earnings · signals, first Subscribe Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor. This article reflects information as of June 29, 2026. US STOCK TODAY Editorial Team Every figure is calculated directly from filings and market data. How we work Today's 5 AI picks, all free Nothing hidden: past picks and how they did against the S&P 500. See today's picks →